The study authors, led by Dr. Wafik El-Deiry, director of the Cancer Center at Brown University, exposed cancer cells to spike protein subunits. They found that the spike subunits may promote cancer survival and growth by blocking a cancer suppressor gene known as p53.Dr. El-Deiry’s study was designed to test whether the SARS-CoV-2 virus or its viral subunits could promote cancer activities.
However, the study further implied that SARS-CoV-2 therapeutics like the COVID-19 mRNA and protein vaccines may yield similar effects.
"Our goal was to study spike protein regardless of its origin," Dr. El-Deiry told The Epoch Times. "We focused on spike that may come from infection or any other way it can be expressed in human cells... this would also apply to vaccine-made spike."
Dr. El-Deiry was careful to highlight the many limitations of his study, including that it was a simple cell culture study. Additionally, with differing spike variations in the different viral strains and vaccines, the health consequences they may have require more research.
But of course!